Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.

Machine translation Machine translation
类别 Primary study
期刊Archives of physical medicine and rehabilitation
Year 1997
連結 Pubmed, DOI
目的：确定是否吡拉西坦​​4.8克/天，连同密集的语言治疗改善语言功能更比语言治疗。 设计：双盲，安慰剂对照平行组研究。 单位：一所大学神经科诊所转介语音和语言。 患者66例住院患者与失语之间存在4周和36个月。 干预措施：强化语言治疗6周，所有患者。32例患者接受吡拉西坦4.8克每天，34例接受安慰剂。 主要观察指标：亚琛失语症测验（AAT），失语的严重程度评价的标准程序，是在基线和治疗后6周。 结果：在50例患者的疗效进行评估，改善的趋势在所有检测子的AAT中的活性基团。这种趋势的“书面语言”和“配置文件级别的恢复绝对差异有统计学显着性。” 结论：吡拉西坦出现失语的恢复有积极的辅助治疗效果，患者接受密集的语言治疗。
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: 8d710e54483d4d33f7647033a1e1f7a18180f532
First added on: Feb 01, 2013
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use